Japan Health Ministry To Review Study Exonerating Tamiflu
This article was originally published in PharmAsia News
Japan's Health Ministry is expected to cancel a warning it had ordered on Roche's Tamiflu (oseltamivir) for teenagers after a study found no link to mental problems. The government-funded study completed by an Osaka City University professor found that children given the flu vaccine did not demonstrate psychotic behavior beyond normal levels. The ministry will use the study for a report of its own and a review of it by its drug safety committee, according to a ministry official. Tamiflu was required to carry the warning label after reports of psychotic behavior among youth under the age of 18 who had received the drug. (Click here for more
You may also be interested in...
The EU pharmaceutical strategy published on 25 November will be the first step in a “complete overhaul” of the medicines legislative framework to be proposed in about two years’ time, says the European Commission.
The European Commission’s newly-published Pharmaceutical Strategy features a range of proposals related to generics and biosimilars, including “targeted policies” to improve competition, remove barriers and increase uptake.
Pfizer’s efforts to circumvent two US patents shielding Par’s Adrenalin (epinephrine) have again ended in failure, following a ruling by the US Court of Appeals for the Federal Circuit.